| Trial ID: | L0588 |
| Source ID: | NCT04072861
|
| Associated Drug: |
Rbt-9
|
| Title: |
A Study of RBT-9 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT04072861/results
|
| Conditions: |
Healthy Volunteers|Chronic Kidney Disease
|
| Interventions: |
DRUG: RBT-9
|
| Outcome Measures: |
Primary: Effect of RBT-9 on Plasma Ferritin Levels, Percent Change in Plasma Ferritin From Baseline to 24 hours, 24 hours post-infusion|Effect of RBT-9 on Plasma HO-1 Levels, Percent Change in Plasma HO-1 From Baseline to 24 hours, 24 hours post-infusion|Effect of RBT-9 on Plasma IL-10 Levels, Percent Change in Plasma IL-10 From Baseline to 24 hours, 24 hours post-infusion |
|
| Sponsor/Collaborators: |
Sponsor: Renibus Therapeutics, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
42
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2019-03-31
|
| Completion Date: |
2020-10-31
|
| Results First Posted: |
2025-01-06
|
| Last Update Posted: |
2025-01-06
|
| Locations: |
Riverside Clinical Research, Edgewater, Florida, 32132, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT04072861
|
